Clobazam
Product Images NDC 51672-4202

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Clobazam (NDC 51672-4202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Clobazam 01)

Chemical Structure (Clobazam 01)
Chemical structure of Clobazam showing its molecular arrangement including a chlorophenyl group and a benzodiazepine core with nitrogen and oxygen atoms.*
FDA Label Image

Figure 1 (Clobazam 02)

Figure 1 (Clobazam 02)
A bar chart showing percentage reduction in weekly drop seizure rate for Clobazam groups labeled Placebo, Low, Medium, and High. The chart shows increasing effectiveness with higher dosage, with reductions of approximately -12.1%, -41.2%, -49.4%, and -68.3%, respectively. Sample sizes for each group are included below the labels.*
FDA Label Image

Figure 2 (Clobazam 03)

Figure 2 (Clobazam 03)
A bar graph illustrating the proportion of patients (%) experiencing different ranges of reduction in weekly drop seizure frequency from baseline (%). The graph compares four groups: Placebo, Clobazam Low, Clobazam Medium, and Clobazam High doses, across six categories of seizure frequency reduction: Worse, 0 to <20%, 20 to <40%, 40 to <60%, 60 to <80%, and 80 to 100%. Higher Clobazam doses correspond with higher proportions of patients in the greater reduction categories.*
FDA Label Image

Principal Display Panel (10 mg Tablet Bottle Label)

Principal Display Panel (10 mg Tablet Bottle Label)
Clobazam Tablets 10 mg label showing a 100-tablet count. The label includes storage instructions, prescribing information notice, and dispensed medication guide advisory. Manufactured by Taro Pharmaceutical Industries Ltd. and distributed by Taro Pharmaceuticals U.S.A., Inc. The label also displays the NDC number and a barcode.*
FDA Label Image

Principal Display Panel (20 mg Tablet Bottle Label)

Principal Display Panel (20 mg Tablet Bottle Label)
Label for Clobazam Tablets 20 mg, containing 100 tablets, manufactured by Taro Pharmaceutical Industries Ltd. and distributed by Taro Pharmaceuticals U.S.A., Inc. The label includes storage instructions and indicates the product is prescription only (Rx only).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.